Screening Volunteers for Clinical Trials

Status Recruiting

Clinical Trial Summary

Background: - The National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health needs healthy volunteers for vaccine clinical trials. This is a screening study that is used to identify healthy volunteers who may be eligible to participate in other clinical trials at the Vaccine Research Center that evaluate investigational vaccines, monoclonal antibodies, and injection devices. The VRC conducts studies that will allow researchers to better understand the immune system and how vaccines and monoclonal antibodies work. Objectives: - To screen healthy volunteers for clinical trials at the NIAID VRC. Eligibility: - Healthy people between 18 and 60 years of age. They must be available to take part in clinical trials and be able to provide blood for research studies. Design: - Screening for healthy volunteers to participate in clinical trials is an ongoing process. - Volunteers will be asked about their medical history, including sexual activity and drug use, and a detailed physical exam will be performed. - Blood and urine samples may be collected, and possibly other tests as needed to evaluate the volunteer's health status. - Volunteers will not receive any investigational product in this screening protocol....

Clinical Trial Description

The purpose of this study is to recruit and screen potential study subjects, mostly healthy volunteers, to determine if they are eligible for clinical trials of investigational products. This screening study also aims to characterize and analyze demographic information as well as laboratory and other medical findings in terms of how they may affect the eligibility of subjects for specific early phase clinical trials. All work will be conducted by the VRC Clinic of the National Institutes of Health or other IRB-approved sites that are collaborating with NIAID/VRC. Educational and recruitment materials on the investigational products and protocols will be reviewed with and provided to subjects during participation in the screening protocol. ;

Study Design

Related Conditions & MeSH terms

Screening

Clinical Trial Details

NCT number	NCT01375530
Study type	Observational
Source	National Institutes of Health Clinical Center (CC)
Contact	VRC Recruitment
Phone	(866) 833-5433
Email	vrcrecruitment@mail.nih.gov
Status	Recruiting
Phase
Start date	August 16, 2011

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05120167` - Strategies for Endocervical Canal Investigation in Women With Abnormal Screening Cytology and Negative Colposcopy	N/A
Completed	`NCT01820234` - Evaluation of Store-and-Forward Teledermatology Versus a Face-to-Face Assessment During a Skin Cancer Screening Event	N/A
Completed	`NCT01140022` - Leveraging Technology as a Clinician Extender to Screen Culturally Diverse Young Women for Chlamydia	N/A
Completed	`NCT04240418` - Initiative in LYon for Lung cAncer Screening Development - Prevalence Study
Recruiting	`NCT03937583` - Screening for Cancer in Patients With Unprovoked VTE	Phase 4
Completed	`NCT00115557` - Delivery of Preventive Services in Primary Care	N/A
Recruiting	`NCT05880173` - SCREaning of Advanced Liver Fibrosis Using Non-Invasive Tests in General Population	N/A
Recruiting	`NCT05884840` - New Cardiovascular Risk Screening Strategy.	N/A
Recruiting	`NCT05460975` - Breast Cancer Risk From Sonographic Glandular Tissue Component (or International GTC Study)
Not yet recruiting	`NCT06416501` - The Impact of Colorectal Cancer Screening on Surgical Outcomes
Completed	`NCT02727894` - Colorectal Cancer: Screening vs. Non-Screening
Active, not recruiting	`NCT03861741` - A Study to Evaluate the Feasibility of Screening Relatives of Patients Affected by Non-Syndromic Thoracic Aortic Diseases	N/A
Completed	`NCT04644874` - Geriatric Oncology Screening of Older Patients With Solid Cancers
Completed	`NCT01626703` - Effect of Depressin Screening and Care Program at Community Health Center	N/A
Completed	`NCT00582829` - Colorectal Cancer Screening Intervention for Family Members of Colorectal Cancer Patients	Phase 0
Enrolling by invitation	`NCT04171830` - Clinical Surveillance Tool to Screen for Unmet Palliative Needs Among Patients in the Final Year of Life	N/A
Completed	`NCT05489978` - Effectiveness of a Cervical Cancer Stigma Reduction Intervention Program on Cancer Stigma Score and Cervical Cancer Screening Uptake in Nepal	N/A
Completed	`NCT04684316` - Economic Evaluation of Periodic Occupational Health Screening	N/A
Completed	`NCT01427829` - Computer-assisted Psychosocial Risk Assessment (CaPRA) for Refugee Health and Settlement	N/A
Recruiting	`NCT04221854` - Stool-based SDC2 DNA Methylation Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.